Verve Therapeutics
VERV
#7012
Rank
$0.41 B
Marketcap
$4.85
Share price
5.43%
Change (1 day)
-57.60%
Change (1 year)

Verve Therapeutics (VERV) - Cash on Hand

Cash on Hand as of September 2024 : $0.53 Billion USD

According to Verve Therapeutics's latest financial reports the company has $0.53 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Verve Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.62 B12.46%
2022-12-31$0.55 B53.92%
2021-12-31$0.36 B399.84%
2020-12-31$72.11 M283.94%
2019-12-31$18.78 M